162 related articles for article (PubMed ID: 34411893)
1. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
[TBL] [Abstract][Full Text] [Related]
2. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
Fu SK; Cheng LP
Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
[TBL] [Abstract][Full Text] [Related]
5. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel acylhydrazone neuraminidase inhibitors.
Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of NH
Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel polyheterocyclic neuraminidase inhibitors with 1,3,4-oxadiazole thioetheramide as core backbone.
Shang LL; Zhong ZJ; Cheng LP
Eur J Med Chem; 2024 Apr; 269():116305. PubMed ID: 38518525
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
12. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
Yu W; Ping Cheng L; Pang W; Ling Guo L
Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
[TBL] [Abstract][Full Text] [Related]
14. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of
Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
[TBL] [Abstract][Full Text] [Related]
17. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
[TBL] [Abstract][Full Text] [Related]
19. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
[TBL] [Abstract][Full Text] [Related]
20. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
